Cd Private Equity Etf Beneish M Score
| CD3 Etf | 1.30 0.04 3.17% |
CD3 |
At this time, CD Private's M Score is inapplicable. The earnings manipulation may begin if CD Private's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by CD Private executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of CD Private's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
About CD Private Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CD Private Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CD Private using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CD Private Equity based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in CD3 Etf
CD Private financial ratios help investors to determine whether CD3 Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CD3 with respect to the benefits of owning CD Private security.